Abnormal Hormonal Secretions Post Radiotherapy for Nasopharyngeal Cancer*

Authors

  • Vimol Sukthomya Radiology Department. Faculty of Medicine, Chiangmai University

Abstract

Objective: To investigate the incidence of abnormal hormone level in the nasopharyngeal cancer patient who received radiotherapy.

Materials and Methods: We have studied the incidence of abnormal function of adrenal and thyroid gland in patients with nasopharyngeal cancer who received radiotherapy at Division of Therapeutic Radiology and Oncology, Faculty of Medicine, Chiang Mai University. There were 60 patients, 36 male, 24 female. All patients were examined clinically and laboratory for signs of abnormal thyroid function. All patients had blood tests to determine the free hormone from thyroid and pituitary glands (TSH, FT3, FT4) and adrenal glands by using insulin tolerance test then reconfirm by using pituitary hormone injection intravenously to check the function of adrenal gland (ACTH Stimulation test).

Results: The result revealed abnormal function of adrenal glands 13.3%, abnormal thyroid function 65% in which 38.3% come from abnormality of the pituitary gland and hypothalamus (central hypothyroid) and primary hypothyroidism in 18.3%. Subclinical hyperthyroid was found in 8.3%. But we were not able to differentiate signs and symptoms of the patients with adrenal insufficiency and hypothyroidism from patients who have normal level of hormone.

Conclusion: This study found high incidence of abnormal hormone level in the nasopharyngeal cancer patient who received radiotherapy.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Chiang Mai Cancer Registry. Annual Report 2006.

Khuhaprema T. Srivatanakul P, Sriplung H. Wiangnon S. Sumitsawan Y, Attasara P. Cancer in Thailand 1998-2000. Vol.IV. Bangkok Edical Publisher. 2007.

Bhandare N, Kennedy L, Morris G, Malyapa R, Mendenhall WM. Hypopituitarism after radiation therapy for extracranial head and neck cancers. Int J Radiat Oncol Biol Phys 2006:66(3):5187.

Blatt J, Lee P, Suttner J. Finegold D. Pulsatile growth hormone secretion in children with acute lymphoblastic leukemia after 1800 cGy cranial irradiation. Int J Radiat Oncol Biol Phys 1988;15:1001-6.

Constine LS. Woolf PD, Cann D. Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med 1993:328:87-94.

Fernandez A, Brada M. Zabuliene L, Karavitaki N, Wass J. Radiation-induced hypopituitarism. Endocrine-Related Cancer 2009:16(3):733-72.

Gleeson HK, Shalet SM. The impact of cancer therapy on the endocrine system is survivors of childhood brain tumours. Endocrine-Related Cancer 2004:11(4):589-602.

Littley MD, Shalet SM.Beardwell CG. Hypopituitarism following external radiotherapy for pituitary tumor in adults. Q J Med 1989;262:145-60.

Pomarede R, Czernichow P, Zucker JM. anterior pituitary deficiency after radiotherapy at an early age: study in retinoblastoma. Acta Pediatr Scand 1984:73: 115-9.

Samaan NA, Schultz PN. Yand KP. Endocrine complications after radiotherapy for tumors of head and neck. J lab clin Med 1987:38:364-72.

Shalet SM, Beardwell CG, Morris-Jones PH, Pearson D. Pituitary function after treatment of intracranial tumor in children. Lancet 1975;2:104-7

Yuen K, Cook D, Ong K, Chatelain P, Frykund L, Gluckman P. et al. The metabolic effects of short-term administration of physiological versus high doses of GH therapy in GH deficient adults. Clinical Endocrinology 2002:57:333-41

Yoon SC, Suh TS, Jang HS. Chung SM. Kim YS. Ryu MR, et al. Clinical results of 24 pituitary macroadenomas with linac-based stereotactic radiotherapy. International Journal of Radiation Oncology, Biology. Physics 1998:41:849-53.

Lam KSL, Tse VK. Wang C. Effect of cranial irradiation on hypothalamic-pituitary function: 5-year longitudinal study in patients with nasopharyngeal carcinoma. Q J Med 1991:78:165-76.

Turner SL, Tiver KW. Thyroid dysfunction following radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 1995:31:279-90.

Tunbridge WMG, Evered DC, Hall R. The spectrum of thyroid disease in a community: The whickham survey Clin Endocrinol 1977;7:481.

Helfand M, Bengtsson C, Lindquist O. Thyroid disease and high concentration of serum thyrotropin in a population sample of women. Acta Med Scand 1981:210:39-46.

Arem R, Escalante D. Subclinical hypothyroidism: epidemiology, diagnosis. and significance. Adv intern med 1996: 41:213-37.

Grande C. Hypothyroidism following radiotherapy for head and neck cancer: multivariate analysis of risk factors Radiother Oncol 1992:25:31-6.

Posner MR, Ervin TJ, Fabian RL. Incidence of hypothyroidism following multimodality treatment for advanced squamous cell cancer of the head and neck. Laryngoscope 1984:94:451-4

Ponsner MR, Weichselbaum RR, Fitzgerald JJ. Treatment complications after sequential combination chemotherapy and radiotherapy with or without surgery in previously untreated squamous cell carcinoma of the head and neck Int J Radiat Oncol Biol Phys 1985:11:1887-93.

Alterio D, Jereczek-Fosssa B.Franchi B, D'Onofrio A, Piazzi V. Rondi E, et al. Thyroid disorders in patients treated with radiotherapy for head and neck cancer: A retrospective analysis of seventy-three patients. Int J Radiat Oncol Biol Phys 2007:67(1):144-50.

Bhandare N. Kennedy L. Malyapa R. Morris CG, Mendenhall WM. Primary and central hypothyroidism after radiotherapy for head and neck tumor. Int. J Radiat Oncol Biol Phys 2007:68(4):1131-9.

Diaz R. Jaboin JJ. Morales-Paliza M. Koehler E. Phillips JG, Stinson S. et al. Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head and neck cancer. Int J Radiat Oncol Biol Phys 2009:75: 1-9.

Tell R. Lundell G. Nilsson B, Sjodin H, Lewin F, Lewensohn R. Long-term incidence of hypothyroidism after radiotherapy in patients with head and neck cancer. Int J Radiat Oncol Biol Phys 2004:60(2):395-400.

Wu YH, Wang HM, Chen HHW, Lin CY, Chen EYC, Fan KH. et al. Hypothyroidism after radiotherapy for nasopharyngeal cancer patients. Int J Radiat Oncol Biol Phys 2010:76(4):1133-9.

Sukthomya V. Sukthomya C. Thyroid dysfunction following external radiation for head and neck cancer. Thai J radio 1988:24:71-4.

Palmer BB. Gaggar N. Shaw HJ. Thyroid function after radiotherapy and laryngectomy for carcinoma of the larynx. Head and Neck Surg 1981:4:13-5

Howes EL, Suoy JW. Harvey SC. The healing for wounds as determined by their tensite strength. JAMA 1929:92: 42-95.

Feehs RS, McQuirt WT, Bond MG. Irradiation: A significant factor for carotic artherosclerosis. Arch Otolaryngol Head and Neck Surg 1991:117:1135-7.

Markson JL, Flatman GE. Myxedema after deep x-ray therapy to the neck. South Med J 1965:1:1228-30.

Downloads

Published

2023-04-28

How to Cite

1.
Sukthomya V. Abnormal Hormonal Secretions Post Radiotherapy for Nasopharyngeal Cancer*. ASEAN J Radiol [Internet]. 2023 Apr. 28 [cited 2024 May 9];16(2):130-8. Available from: https://www.asean-journal-radiology.org/index.php/ajr/article/view/851

Issue

Section

Original Article